The estimated Net Worth of Venture Partners Viii, L.P.... is at least $2.7 Million dollars as of 13 October 2015. Venture P owns over 409,090 units of Aclaris Therapeutics Inc stock worth over $2,701,586 and over the last 9 years Venture sold ACRS stock worth over $0.
Venture has made over 1 trades of the Aclaris Therapeutics Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Venture bought 409,090 units of ACRS stock worth $4,499,990 on 13 October 2015.
The largest trade Venture's ever made was buying 409,090 units of Aclaris Therapeutics Inc stock on 13 October 2015 worth over $4,499,990. On average, Venture trades about 409,090 units every 0 days since 2015. As of 13 October 2015 Venture still owns at least 2,289,480 units of Aclaris Therapeutics Inc stock.
You can see the complete history of Venture P stock trades at the bottom of the page.
Over the last 9 years, insiders at Aclaris Therapeutics Inc have traded over $101,608,525 worth of Aclaris Therapeutics Inc stock and bought 10,163,038 units worth $66,383,599 . The most active insiders traders include Braden Michael Leonard, Capital Management, Llc Kol... und Llc Fmr. On average, Aclaris Therapeutics Inc executives and independent directors trade stock every 17 days with the average trade being worth of $111,818. The most recent stock trade was executed by Kevin Balthaser on 1 September 2024, trading 1,000 units of ACRS stock currently worth $1,180.
aclaris therapeutics, inc. is a dermatologist-led biopharmaceutical company committed to identifying, developing and commercializing innovative therapies to address significant unmet needs in dermatology, both medical and aesthetic, and immunology. aclaris is focused on market segments with no fda-approved medications or where treatment gaps exist. aclaris was founded by dermatologists and is led by a team with extensive experience in developing and commercializing dermatologic treatments.
Aclaris Therapeutics Inc executives and other stock owners filed with the SEC include: